Ikarian Capital, LLC Trillium Therapeutics Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Trillium Therapeutics Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 198,400 shares of TRIL stock, worth $0. This represents 0.25% of its overall portfolio holdings.
Number of Shares
198,400Holding current value
$0% of portfolio
0.25%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
About Trillium Therapeutics Inc.
- Ticker TRIL
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,995,000
- Market Cap $1.94B